Correspondence to Dr Ronald Wai, Palliative Medicine, Illawarra Shoalhaven Local Health District, Wollongong, New South Wales, Australia; ronald.k.h.wai{at}gmail.com Pruritis is a common symptom in ...

Correspondence to Dr Helen Crispin, Palliative Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, UK; helen.crispin{at}uhs.nhs.uk In palliative care, we have a small number ...

What is known about the role of clinical ethics services in cancer care? A systematic/narrative literature review ...

Correspondence to Dr Mette Asbjoern Neergaard, Palliative Care Unit, Department of Oncology, Aarhus University Hospital, Aarhus 8200, Denmark; mettneer{at}rm.dk If you wish to reuse any or all of this ...

Background Cholestatic itch is caused by intrahepatic liver diseases, such as primary biliary cirrhosis and extrahepatic obstruction of the biliary tree, often caused by tumours. The pathophysiology ...

Objectives The most common treatment for locally advanced and metastatic lung cancer is best supportive care. Patients with lung cancer are often comorbid with a high symptom burden. We wanted to ...

Correspondence to Dr Deborah Lam, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK; deborah.lam{at}nhs.net Fentanyl has a low molecular weight and is lipophilic ...

2 Department of Pain Medicine, Erasmus MC, Rotterdam, The Netherlands 3 Department of Medical Oncology, Erasmus MC, Rotterdam, The Netherlands Correspondence to Joost L Jongen, Department of Neurology ...

Background Stroke is often associated with long term morbidity and increased mortality risks of up to 30% within the first year.1 Advance Care Planning (ACP) has a role in ensuring good delivery of ...

Objectives To investigate the efficacy and safety of subcutaneous clonidine for refractory symptoms in the palliative setting. Methods A retrospective chart review of the use of subcutaneous clonidine ...

Background Morbidity and mortality (M&M) meetings are a recognised tool for improving quality of care. We have developed an M&M process within the HSPCT at University Hospitals of Leicester (UHL).

Access to injectable medicines in the community is crucial for people wishing to die at home. Previous surveys in South Australia in 2012 demonstrated only 6% of pharmacies were able to facilitate ...